We hypothesized that there would be a relationship between baseline tumor and plasma levels of OPN, that both would have prognostic value in early breast cancer, and that breast cancer recurrence would be associated with elevated plasma OPN levels. The gene discussed is SPP1; the disease is breast carcinoma.